We’re proud supporters of ISCTM and look forward to participating in this independent, multi-disciplinary organization dedicated to advancing clinical research for CNS therapeutics. ISCTM collaborates with academia, industry, government, and the public to tackle challenges in the field—and we share their mission to improve clinical trial methods for CNS disorders such as Alzheimer’s, depression, and other neurological and psychiatric conditions.
Book a meeting in our suite and discover how Clinilabs can take your project from start to regulatory approval.
